Welcome to a very special edition of Conversations on MS! This session features three MS-specialist neurologists answering frequently asked questions. Dr. John Corboy moderates the event. Corboy is the Medical…
The MS Center’s Tom Stewart, M.S., PA-C, J.D. presents an informative webinar on two important topics for Colorado residents. Stewart provides a review of Colorado’s new paid Family Medical…
We are saddened to share that Dr. Jack Burks passed away on November 18, 2022. Dr. Burks was a core founder of the Rocky Mountain MS Center, and was at…
NfL and GFAP as Measures of Disease Progression Prospective study to evaluate Neurofilament Light (NfL) and glial fibrillary acidic protein (GFAP) as biomarkers for disease progression over time in patients…
Biomarkers are biological markers that can be used in diagnosis, selecting treatments, and evaluating treatment responses. Having pre-collected samples is invaluable for this research, and the Biobank ensures that researchers…
In this issue, weโve compiled six reports on โhot topicsโ in the MS world. These topics are based on both input from the Rocky Mountain MS Center medical team, and…
COVID-19 continues to twist and turn as new variants become more predominant. The BQ1 and BQ1.1 variants have become the dominant strains in the US as of mid-November. These variants…
Saturday, September 17 was truly a special evening, as we welcomed more than 300 guests, supporters, sponsors, family and friends to the MS Centerโs Annual Gala at the Sheraton Denver…
The Rocky Mountain MS Center medical team continues to recommend a full course of available COVID-19 vaccines and boosters for most MS patients, with exceptions being those who have had…